![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-α antibody
The role of tumor necrosis factor-α in the shedding of soluble tumor necrosis factor receptors in endotoxemia was investigated. The appearance of the soluble tumor necrosis factor receptors was assessed in four h...
-
Article
Acute hepatitis in a patient using a Chinese herbal tea ‐ a case report.
A case is presented of reversible acute hepatitis in a patient using a Chinese herbal tea. Upon identification of the tea mixture Aristolochia species, including A. debilis, which contains the highly toxic ari...
-
Article
Current Drug Treatment Strategies for Disseminated Intravascular Coagulation
Disseminated intravascular coagulation (DIC) can be caused by a variety of diseases. Experimental models of DIC have provided substantial insight into the pathogenesis of this disorder, which may ultimately re...
-
Article
Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits
Severe thrombocytopenia frequently occurs in patients receiving chemotherapy and in patients with autoimmune disorders. Thrombocytopenia is associated with bleeding, which may be serious and life threatening1,2,3
-
Article
Pathogenesis of DIC in Sepsis
Sepsis can be associated with profound alterations in the hemostatic mechanism. In this article we discuss recent insights into which mediators are involved in the activation of the coagulation system. We focu...
-
Article
Relative Insufficiency of the Fibrinolytic System in Disseminated Intravascular Coagulation
Experimental and clinical observations indicate that the systemic deposition of fibrin in disseminated intravascular coagulation (DIC) is insufficiently counteracted by endogenous fibrinolysis. In fact, a mark...
-
Article
Mouse models of focal arterial and venous thrombosis
Mouse models of arterial and venous thrombosis have gained increasing interest over the last 15 years, due to direct availability of a growing number of genetically modified mice, improved technical feasibili...
-
Chapter
Hemostasis and Coagulation
Bleeding is one of the major complications of surgery. Serious intraoperative and postoperative bleeding may be caused by a local problem in surgical hemostasis, such as a failed ligature, but can also be caus...
-
Chapter
Coagulation and Fibrinolysis During Endotoxemia and Gram-Negative Sepsis
Severe gram-negative infections are sometimes associated with the clinical syndrome of disseminated intravascular coagulation (DIC). The derangement of the hemostatic mechanism not only comprises enhanced acti...
-
Article
Drotrecogin Alfa (Activated)
-
Chapter
Hemostasis and Coagulation
-
Article
Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis
-
Article
Sepsis and Disseminated Intravascular Coagulation
Sepsis almost invariably leads to hemostatic abnormalities, ranging from insignificant laboratory changes to severe disseminated intravascular coagulation (DIC). There is compelling evidence from clinical and ...
-
Article
Prevention and Treatment of Bleeding by Pro-hemostatic Treatment Strategies
Pro-hemostatic therapy may achieve an improvement of hemostasis, by amelioration of primary hemostasis, stimulation of fibrin formation or inhibition of fibrinolysis. Pro-hemostatic interventions appear to be ...
-
Article
Coagulation in sepsis: all bugs bite equally
Sepsis almost invariably leads to hemostatic abnormalities, ranging from insignificant laboratory changes to severe disseminated intravascular coagulation. There is compelling evidence from clinical and experi...
-
Article
Open AccessFactors that predict outcome of intensive care treatment in very elderly patients: a review
Advanced age is thought to be associated with increased mortality in critically ill patients. This report reviews available data on factors that determine outcome, on the value of prognostic models, and on pre...
-
Article
Open AccessRecombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study
Recombinant human activated protein C (rhAPC) is the first drug for which a reduction of mortality in severe sepsis has been demonstrated. However, the mechanism by which this reduction in mortality is achieve...
-
Article
Antithrombin in sepsis revisited
As the pivotal phase III randomized controlled clinical trial on antithrombin concentrate in patients with severe sepsis did not show a beneficial effect of antithrombin treatment on 28-day mortality, the inte...
-
Article
Prescription of rh-APC differs substantially among western European countries
-
Article
Coagulation abnormalities in critically ill patients
Many critically ill patients develop hemostatic abnormalities, ranging from isolated thrombocytopenia or prolonged global clotting tests to complex defects, such as disseminated intravascular coagulation. Ther...